Top line contracting.
−27.1% YoY versus +2.2% prior. 3y CAGR −9.1%.
−27.1%We use cookies
MainRatios uses cookies for essential site functions. With your consent, we also use analytics cookies including session replay sampling (PostHog, Google Analytics) and advertising cookies (Google AdSense). You can reject non-essential cookies, including the "sale" or sharing of personal information under CCPA, and you may withdraw consent at any time (GDPR). See our Privacy Policy for details.
Healthcare · Market Cap: $9.4B
Live price unavailable
Fundamentals as of 2026-04-04
All analysis on this page is for educational purposes only and does not constitute financial advice. Fair values are model-based estimates. Always do your own research.
The Question
Bottom line: MASI currently has no legendary investor models qualifying — see /stock/MASI/valuation for the per-model breakdown, but earns a D sector grade (31/100) in Healthcare. Use the per-tab analysis to form your own view. Drill into the valuation breakdown and sector ranking for the full picture.
Concerns — Masimo Corporation's 9.7% ROE is below sector median.
Financial story
Concerns — Masimo Corporation's 9.7% ROE and 1.08 debt-to-equity warrant a closer look at the underlying business.
Masimo Corporation's fair value depends on which model you trust. See the per-investor fair-value table in the valuation tab.
MASI trades at 122.1x earnings. Sector context and per-investor signals are in the valuation tab.
MASI and DVA differ on P/E, ROE, and revenue growth. See the full MASI vs DVA compare matrix.
Investor verdicts for MASI are listed in the valuation tab. Per-model fair value and reasoning are in the valuation tab.
MASI's P/E ratio is 122.1x. 5-year P/E history is in the financials tab.
Investor verdicts vary by methodology. Full breakdown by investor and signal is in the valuation tab.
−27.1% YoY versus +2.2% prior. 3y CAGR −9.1%.
−27.1%Net margin −9.9% versus −14.6% prior (+4.6pp). Operating 20.5%.
−9.9%P/E 122.5x — 94% above the 5y median of 63.2x. Forward 32.5x hints at EPS expansion next year.
122.5xHow does MASI compare?
See exactly where MASI ranks
Sign in to unlock the full sector ranking — free.
Sign in to see the rankingMASI sits at #107 in Healthcare with a D grade (31/100).